Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 10, 2025Journal of Medical - Clinical Research & ReviewsOpen Access

Polycythemia Vera – A Myeloproliferative Disorder

View Full Paper
Ask AI
Bookmark
Share

Authors

SSSophie SompayracVGVincent S Gallicchio

Discussion

Loading...

Member takes

Overview

Observational analysis highlights the role of JAK mutations and symptoms in polycythemia vera, indicating effective management strategies.

Key Points

  • Polycythemia vera leads to increased blood viscosity and cardiovascular complications.
  • Key diagnostic criteria include elevated red blood cell counts and JAK2 mutations.
  • Treatment typically involves phlebotomy and cytoreductive agents like hydroxyurea.
  • Advanced cases may necessitate stem cell transplants, although risks are involved.

Cite This Study

Sompayrac et al. (2025) studied this question.

synapsesocial.com/papers/68c2404eb210217d6479a0cchttps://doi.org/10.33425/2639-944x.1410
View Full Paper
Ask AI
Bookmark
Share